Adhesion molecule expression in postischemic microvascular dysfunction: activity of a micronized purified flavonoid fraction
- PMID: 10474047
- DOI: 10.1159/000054070
Adhesion molecule expression in postischemic microvascular dysfunction: activity of a micronized purified flavonoid fraction
Abstract
Ischemia and reperfusion (I/R) induces neutrophil infiltration in skeletal muscle that is localized to the ischemic region. To transmigrate at ischemic regions, granulocytes must first arrest in the postcapillary venular segment of the microcirculation. Initially, leukocytes roll along the endothelium of these venules, a weak adhesive interaction that is mediated by the selectins (L-, E-, and P-selectin). Leukocyte rolling functions to slow the neutrophil during its transit through the microcirculation, thereby allowing it to monitor its local environment for the presence of activating factors arising from the ischemic tissues. When activated, the rolling granulocyte is rendered capable of forming the stronger adhesive interactions that allow the cell to become arrested in postcapillary venules in the ischemic region. These adhesive interactions are mediated by a leukocyte glycoprotein complex designated CD11/CD18 and intercellular adhesion molecule-1 (ICAM-1) expressed on endothelial cells. The stationary neutrophil uses the gradient in concentration of soluble chemoattractants liberated from ischemic tissues as a directional cue to move from the vascular to extravascular compartment, being guided in its transit across the endothelium by interactions with platelet endothelial cell adhesion molecule-1 (PECAM-1), an adhesive molecule localized to the interendothelial cleft. This paper reviews current understanding of the mechanisms underlying the establishment of leukocyte/endothelial cell interactions in postischemic skeletal muscle in terms of specific adhesion molecules that participate in neutrophil sequestration after I/R. Discovery of the molecular determinants of neutrophil/endothelial cell adhesion has uncovered potential mechanisms whereby agents exhibiting anti-adhesive properties may act. The micronized purified flavonoid fraction (450 mg diosmin, 50 mg hesperidin) prevents I/R-induced leukocyte adhesion in skeletal muscle. This anti-adhesive effect appears to be mediated at least in part by inhibition of induced expression of ICAM-1.
Similar articles
-
ICAM-1 expression and leukocyte behavior in the microcirculation of chronically ischemic rat skeletal muscles.Microvasc Res. 2006 May;71(3):205-11. doi: 10.1016/j.mvr.2006.03.003. Epub 2006 May 2. Microvasc Res. 2006. PMID: 16647725
-
Effects of the phlebotropic drug Daflon 500 mg on postischemic microvascular disturbances in striated skin muscle: an intravital microscopic study in the hamster.J Lab Clin Med. 1999 Nov;134(5):526-35. doi: 10.1016/s0022-2143(99)90175-0. J Lab Clin Med. 1999. PMID: 10560947
-
Postischemic leukocyte/endothelial cell interactions and microvascular barrier dysfunction in skeletal muscle: cellular mechanisms and effect of Daflon 500 mg.Int J Microcirc Clin Exp. 1997;17 Suppl 1:11-7. doi: 10.1159/000179261. Int J Microcirc Clin Exp. 1997. PMID: 9477039 Review.
-
Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage.Circ Res. 1994 Feb;74(2):336-43. doi: 10.1161/01.res.74.2.336. Circ Res. 1994. PMID: 7507416
-
Ischemia/reperfusion-induced leukocyte-endothelial interactions in postcapillary venules.Shock. 1997 Jul;8(1):16-25. doi: 10.1097/00024382-199707000-00004. Shock. 1997. PMID: 9249908 Review.
Cited by
-
Renal ischemia--reperfusion injury: an inescapable event affecting kidney transplantation outcome.Folia Microbiol (Praha). 2001;46(4):267-76. doi: 10.1007/BF02815613. Folia Microbiol (Praha). 2001. PMID: 11830936 Review.
-
Bibliometric analysis of skeletal muscle ischemia/reperfusion (I/R) research from 1986 to 2022.Heliyon. 2024 Sep 5;10(18):e37492. doi: 10.1016/j.heliyon.2024.e37492. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39309867 Free PMC article.
-
Diosmin protects rat retina from ischemia/reperfusion injury.J Ocul Pharmacol Ther. 2012 Oct;28(5):459-66. doi: 10.1089/jop.2011.0218. Epub 2012 Apr 17. J Ocul Pharmacol Ther. 2012. PMID: 22509733 Free PMC article.
-
Micronized purified flavonoid fraction in pretreating CABG patients.Tex Heart Inst J. 2010;37(2):172-7. Tex Heart Inst J. 2010. PMID: 20401289 Free PMC article. Clinical Trial.
-
Use of Micronized Purified Flavonoid Fraction Together with Rivaroxaban Improves Clinical and Ultrasound Outcomes in Femoropopliteal Venous Thrombosis: Results of a Pilot Clinical Trial.Adv Ther. 2019 Jan;36(1):72-85. doi: 10.1007/s12325-018-0849-z. Epub 2018 Dec 11. Adv Ther. 2019. PMID: 30539384 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous